9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Short Neoadjuvant Hemithoracic IMRT for MPM

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Short Neoadjuvant Hemithoracic IMRT for MPM

Short Neoadjuvant Hemithoracic IMRT for MPM

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 100

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: The primary outcome for the study will be the proportion of patients treated as per protocol without treatment related mortality.,  To evaluate: acute and late morbidity related to treatment; local & distant recurrence, disease free & overall survival; identify factors/parameters associated with increased risk of treatment morbidity,  ,

Interventions: Pre-op RT +/- chemotherapy,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: July 2019

Completion Date: July 2019

Last  Posted Date: September 25, 2018

Location: University Health Network, Toronto, Ontario, Canada

Website Link: https://ClinicalTrials.gov/show/NCT00797719

Was this article helpful?
Dislike 0